July 12, 2019
Ichor CEO to deliver workshop and Lysoclear update at LEAF annual conference
NEW YORK, NY: The second annual Life Extension Advocacy Foundation (LEAF) Ending Age Related Diseases Conference was held in New York City July 11-12th. This conference brought together many of the top minds in the biotechnology rejuvenation field, including Dr. Kelsey Moody, CEO at Ichor Therapeutics, Inc. Dr. Moody also held a workshop prior to the conference, on July 10th.
The workshop was held in the Cooper Union Square as two 1.5-hour sessions. Here, he discussed some of the main elements to developing and maintaining a successful biotechnology company, specifically in the aging field. Dr. Moody has grown Ichor from a living room laboratory into a thriving business with multiple portfolio companies since its creation in 2013. At this workshop, essential tips and key information were shared with attendees regarding how to start and maintain a prosperous business in this industry. This included mechanisms necessary to grow a profitable company and strategic methods used to create a productive work environment necessary to generate ideal results. As the aging population continues to grow exponentially, new medications and treatments will be sought out at unimaginable rates. The aging field is one of the fastest growing in today’s society. Biotechnology companies focused on aging and age-related diseases understand the necessity of taking this research to practical, clinical usage.
For two days following the workshop, a myriad of the top researchers in the aging field presented at LEAF’s Ending Age Related Diseases. Dr. Huda Suliman, president of Ichor’s contract research arm, Icaria Life Sciences, Inc., presented the first day of the conference. She discussed considerations in developing a translational pipeline with a focus on nuances specific to the aging space. On the second day of the conference, Dr. Kelsey Moody presented a research update on Lysoclear’s enzyme augmentation therapy (EAT) for macular degeneration. This research may lead to new treatments for the disease, which affects more than 200,000 US citizens per year and is the leading cause of vision loss in people over 60.
LEAF’s Ending Age Related Diseases conference is a strategic gathering of numerous companies and investors, allowing entities to share current discoveries in the aging field while collaborating with those interested in funding such research. This networking opportunity will return to New York City in 2020.
About the Workshop
Wednesday, July 10th, 201912:00 PM – 3:30 PM
The Cooper Union, 41 Cooper Square, Room 201, New York, NY 10003
About the Conference
July 11-12th, 20198:00 AM – 7:00 PM
Frederick P. Rose Auditorium, 41 Cooper Square, New York, NY 10008
About Ichor Life Sciences
Ichor Life Sciences is a premium pre-clinical contract research organization offering services in discovery through pharmacology. The company operates R&D laboratories in LaFayette and Potsdam, New York, including an AAALAC-accredited vivarium. Services are provided through two divisions. Ichor Discovery Services provides world-class protein manufacturing, as well as a full suite of capabilities in structural biology, biophysics, and assay development. Ichor Pharmacology Services offers in vitro testing, histology, PK/BD, in vivo toxicology, and in vivo efficacy capabilities. Therapeutic areas served by Ichor Life Sciences include oncology, metabolic disease, musculoskeletal disease, ophthalmology, and geriatrics. Ichor Life Sciences was founded in 2013 and is headquartered in New York’s Finger Lakes intellectual corridor.
Do you have questions?
Ichor Life Sciences, Inc.
2561 US Route 11
LaFayette NY 13084
Ichor Life Sciences, Inc.
65 Main Street
Potsdam, NY 13676
At Ichor, we are dedicated to changing the world because we believe we can.